Gavi Vaccine Investment Strategy 2024 VIS 6.0

Gavi's evidence-based Vaccine Investment Strategy (VIS) 2024 outlines immunization priorities and vaccine investments for the 2026–2030 strategic cycle. The strategy employs transparent methodology, analytic review, and expert consultation to identify 19 infectious diseases and evaluate emerging epidemic threats, while providing predictability for vaccine developers, governments, and donors.